135 related articles for article (PubMed ID: 17436000)
1. Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells.
Chang DM; Liu SH; Lee HS; Lai JH; Chen CH
Rheumatol Int; 2007 Sep; 27(11):1049-55. PubMed ID: 17436000
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes.
Tanigawa S; Aida Y; Kawato T; Honda K; Nakayama G; Motohashi M; Suzuki N; Ochiai K; Matsumura H; Maeno M
Cytokine; 2011 Nov; 56(2):376-86. PubMed ID: 21885294
[TBL] [Abstract][Full Text] [Related]
4. The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells.
Shi J; Schmitt-Talbot E; DiMattia DA; Dullea RG
Inflamm Res; 2004 Aug; 53(8):377-89. PubMed ID: 15316669
[TBL] [Abstract][Full Text] [Related]
5. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 does not affect IL-1-induced interleukin-6 and metalloproteinase production in human chondrosarcoma cells, SW1353.
Radons J; Falk W; Schubert TE
Int J Mol Med; 2006 Feb; 17(2):377-83. PubMed ID: 16391840
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.
Lee YJ; Lee EB; Kwon YE; Lee JJ; Cho WS; Kim HA; Song YW
Rheumatol Int; 2003 Nov; 23(6):282-8. PubMed ID: 12684836
[TBL] [Abstract][Full Text] [Related]
8. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.
Lim H; Kim HP
Arch Pharm Res; 2011 Jan; 34(1):109-17. PubMed ID: 21468922
[TBL] [Abstract][Full Text] [Related]
10. Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1alpha and tumor necrosis factor-alpha through a prostaglandin-dependent pathway.
Lin SK; Wang CC; Huang S; Lee JJ; Chiang CP; Lan WH; Hong CY
J Endod; 2001 Mar; 27(3):185-9. PubMed ID: 11487149
[TBL] [Abstract][Full Text] [Related]
11. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects.
Pei Y; Harvey A; Yu XP; Chandrasekhar S; Thirunavukkarasu K
Osteoarthritis Cartilage; 2006 Aug; 14(8):749-58. PubMed ID: 16549373
[TBL] [Abstract][Full Text] [Related]
13. The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes.
Elliott S; Hays E; Mayor M; Sporn M; Vincenti M
Arthritis Res Ther; 2003; 5(5):R285-91. PubMed ID: 12932292
[TBL] [Abstract][Full Text] [Related]
14. Effect of pulsed electromagnetic field on MMP-9 and TIMP-1 levels in chondrosarcoma cells stimulated with IL-1β.
Caliskan SG; Bilgin MD; Kozaci LD
Asian Pac J Cancer Prev; 2015; 16(7):2701-5. PubMed ID: 25854350
[TBL] [Abstract][Full Text] [Related]
15. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes.
Sadowski T; Steinmeyer J
Osteoarthritis Cartilage; 2001 Jul; 9(5):407-15. PubMed ID: 11467888
[TBL] [Abstract][Full Text] [Related]
16. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
Wang L; Almqvist KF; Veys EM; Verbruggen G
Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
[TBL] [Abstract][Full Text] [Related]
17. Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes.
Nemoto O; Yamada H; Kikuchi T; Shinmei M; Obata K; Sato H; Seiki M
J Rheumatol; 1997 Sep; 24(9):1774-9. PubMed ID: 9292803
[TBL] [Abstract][Full Text] [Related]
18. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
19. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
20. Regulation of activin A and inhibin B secretion by inflammatory mediators in adult rat Sertoli cell cultures.
Okuma Y; O'Connor AE; Muir JA; Stanton PG; de Kretser DM; Hedger MP
J Endocrinol; 2005 Oct; 187(1):125-34. PubMed ID: 16214948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
